|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
91,270,000 |
Market
Cap: |
148.77(M) |
Last
Volume: |
511,514 |
Avg
Vol: |
703,791 |
52
Week Range: |
$1.54 - $4.26 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Accuray is a radiation therapy company that develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments. Co.'s technologies, the CyberKnife® and TomoTherapy® platforms, including the Radixact® System, its TomoTherapy platform, are designed to deliver various treatments, including stereotactic radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy, and adaptive radiation therapy. Co. also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other services.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
11,991 |
185,488 |
283,237 |
445,755 |
Total Sell Value |
$31,057 |
$464,222 |
$769,360 |
$1,119,320 |
Total People Sold |
1 |
7 |
7 |
8 |
Total Sell Transactions |
1 |
9 |
18 |
34 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Pettingill Richard |
Director |
|
2015-11-20 |
4 |
D |
$6.80 |
$47,376 |
D/D |
(6,967) |
48,374 |
|
- |
|
Goldstein Jack |
Director |
|
2015-11-20 |
4 |
D |
$6.80 |
$47,376 |
D/D |
(6,967) |
70,671 |
|
- |
|
Davila Elizabeth H |
Director |
|
2015-11-20 |
4 |
D |
$6.80 |
$47,376 |
D/D |
(6,967) |
81,571 |
|
- |
|
Levine Joshua |
President & CEO |
|
2015-11-09 |
4 |
B |
$7.12 |
$356,000 |
D/D |
50,000 |
1,115,830 |
2.74 |
- |
|
Londy Kelly |
EVP Chief Operating Officer |
|
2015-11-02 |
4 |
D |
$6.99 |
$47,113 |
D/D |
(6,740) |
256,107 |
|
- |
|
Waters Kevin |
SVP, Chief Financial Officer |
|
2015-11-02 |
4 |
D |
$6.99 |
$9,374 |
D/D |
(1,341) |
163,940 |
|
- |
|
Nouri Alaleh |
SVP, General Counsel & |
|
2015-11-02 |
4 |
D |
$6.99 |
$12,617 |
D/D |
(1,805) |
113,742 |
|
- |
|
Levine Joshua |
President & CEO |
|
2015-11-02 |
4 |
D |
$6.99 |
$319,114 |
D/D |
(45,653) |
1,065,830 |
|
- |
|
Londy Kelly |
EVP Chief Operating Officer |
|
2015-10-30 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
262,847 |
|
- |
|
Nouri Alaleh |
SVP, General Counsel & |
|
2015-10-30 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
115,547 |
|
- |
|
Levine Joshua |
President & CEO |
|
2015-10-30 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
1,111,483 |
|
- |
|
Waters Kevin |
SVP, Chief Financial Officer |
|
2015-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
165,281 |
|
- |
|
Waters Kevin |
SVP, Chief Financial OfficerOf |
|
2015-09-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100,281 |
|
- |
|
Nouri Alaleh |
SVP, General Counsel & |
|
2015-08-31 |
4 |
S |
$6.80 |
$6,508 |
D/D |
(957) |
65,547 |
|
- |
|
Lichtwardt Gregory |
EVP, Operations |
|
2015-07-08 |
4 |
D |
$6.69 |
$207,517 |
D/D |
(31,019) |
220,585 |
|
- |
|
Lichtwardt Gregory |
EVP, Operations |
|
2015-07-08 |
4 |
A |
$0.00 |
$0 |
D/D |
82,540 |
251,604 |
|
- |
|
Londy Kelly |
EVP Chief Commercial Officer |
|
2015-07-08 |
4 |
D |
$6.69 |
$62,819 |
D/D |
(9,390) |
192,847 |
|
- |
|
Londy Kelly |
EVP Chief Commercial Officer |
|
2015-07-08 |
4 |
A |
$0.00 |
$0 |
D/D |
29,714 |
202,237 |
|
- |
|
Levine Joshua |
President & CEO |
|
2015-07-08 |
4 |
D |
$6.69 |
$332,031 |
D/D |
(49,631) |
911,483 |
|
- |
|
Levine Joshua |
President & CEO |
|
2015-07-08 |
4 |
A |
$0.00 |
$0 |
D/D |
132,064 |
961,114 |
|
- |
|
Londy Kelly |
EVP Chief Commercial Officer |
|
2015-04-30 |
4 |
D |
$8.13 |
$38,422 |
D/D |
(4,726) |
172,523 |
|
- |
|
Nouri Alaleh |
SVP, General Counsel & |
|
2015-03-31 |
4 |
D |
$9.30 |
$21,492 |
D/D |
(2,311) |
66,504 |
|
- |
|
Levine Joshua |
President & CEO |
|
2015-03-31 |
4 |
D |
$9.30 |
$60,478 |
D/D |
(6,503) |
829,050 |
|
- |
|
Levine Joshua |
President & CEO |
|
2015-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
835,553 |
|
- |
|
Nouri Alaleh |
SVP, General Counsel & |
|
2015-02-02 |
4 |
S |
$7.38 |
$30,487 |
D/D |
(4,131) |
68,815 |
|
- |
|
835 Records found
|
|
Page 14 of 34 |
|
|